{"name":"Humacyte, Inc.","slug":"humacyte-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Human Acellular Vessel (HAV)","genericName":"Human Acellular Vessel (HAV)","slug":"human-acellular-vessel-hav","indication":"Vascular access for hemodialysis","status":"phase_3"}]}],"pipeline":[{"name":"Human Acellular Vessel (HAV)","genericName":"Human Acellular Vessel (HAV)","slug":"human-acellular-vessel-hav","phase":"phase_3","mechanism":"Human Acellular Vessel (HAV) is a tissue-engineered vascular graft derived from human cells that provides a biocompatible alternative to synthetic or animal-derived vascular conduits for vascular reconstruction.","indications":["Vascular access for hemodialysis","Peripheral vascular disease requiring bypass grafting","Coronary artery bypass grafting"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxOVTZ6MEZVWExHZWdVYkw4b1BUYjNKOTdWTkNLVHFoZjc0akVZSlJ2TDBOcnBTWFNkMDhKdU55ZUY5TE9KNmRRMVJPS0poRlgwbkVfcXRtVlBfSWtyLWF5NUJPYi1mYThJcDNkNUVUeHBCMmFBdEhqLVJVUklEd3RNcTl0SERfTGs4OEEwOE9xMFo2Mlc2WFNKZndLSWlQYlRnRlhicEtNQlF0TEpvN3ZGTVdTMklKNTJtVktCVEpsdHpvZTZJT1M3UDRDS2ZVeFdNTHJSUmFhV0VhcFE?oc=5","date":"2026-03-31","type":"pipeline","source":"Sahm","summary":"This Rockwell Automation Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Sahm","headline":"This Rockwell Automation Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxNaXoyQWdBQnA4VjNRUVdzNTVRWWF0RW5wWXg4VThSbHBKbjVsRng4clV0X1pQTmw0ZFRMWTBrNDBiZWxXTjdXbWFIcXhlVE9XTDFFX2NOYWdSY0M2UEN0SVhEZmtDazRJT1o1WlpTVTVfQ2xTUlhfZGNtWWVzNWx3eFV2SnM5X01yV1hnOGlYS1JLSHo4V09zQ3VXY0h0SVZqemJzZW1YbERaQjZsT0NwSGE5QQ?oc=5","date":"2026-02-09","type":"pipeline","source":"Seeking Alpha","summary":"Humacyte: Positive News For Symvess At Last, But Long-Term Threats Persist (NASDAQ:HUMA) - Seeking Alpha","headline":"Humacyte: Positive News For Symvess At Last, But Long-Term Threats Persist (NASDAQ:HUMA)","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-12","type":"pipeline","source":"simplywall.st","summary":"While institutions invested in Humacyte, Inc. (NASDAQ:HUMA) benefited from last week's 10% gain, retail investors stood to gain the most - simplywall.st","headline":"While institutions invested in Humacyte, Inc. (NASDAQ:HUMA) benefited from last week's 10% gain, retail investors stood ","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-17","type":"pipeline","source":"simplywall.st","summary":"Humacyte's US$28m Market Cap Fall Books Insider Losses - simplywall.st","headline":"Humacyte's US$28m Market Cap Fall Books Insider Losses","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxOZGdsbXducVlCVF92ZzFNN1p6TGZ3NVFPcElGZlJ5cFYxX2tkQVllYkVXREJYYXFjbXNXWmpaNEVoN3cyWk9yVWpDMll0SVB2ZWdkMXd4aGNTTlNiSUZXQVJSZmRnM1EzVWJYVjM4NUNJQk5nSUw1X05XYmQ0MHFWVG9qcUdPRUo4d3FuWUdUNnFXWDVrLWx2X3FlNmE1dUVYZFlXR1JyZWhYR2s?oc=5","date":"2025-10-30","type":"pipeline","source":"citybiz","summary":"Cartesian Therapeutics Appoints Carsten Brunn, Ph.D., as Board Chairman - citybiz","headline":"Cartesian Therapeutics Appoints Carsten Brunn, Ph.D., as Board Chairman","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQZ1hmd1NCcWR3M0trUGlmckVMa09oV25HcnZFY1VScHZJdjA4a3V0Y1MyM0xmT0FXZS14bGswQmhGRy1QX28ydzNXQ25CTXVPcFItZTBTRjlIalktaDRxQVJaQzgtS1cyOHBFekZ6OEpZc3NwUXRkT1kyUGpyTUNIeVhzME9qSU1seVVXWUlPTXI0Zmc5eV9RN2ttaEkwRVVZR28xSER3?oc=5","date":"2025-10-07","type":"pipeline","source":"Seeking Alpha","summary":"Humacyte: Shares Tank On Fundraising News - What You Need To Know (NASDAQ:HUMA) - Seeking Alpha","headline":"Humacyte: Shares Tank On Fundraising News - What You Need To Know (NASDAQ:HUMA)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE1wdHlCNHMyVWs0cFdXdXZvZk8ybkg5XzlmMVJuUnMyWm55VG5vNzBhbFJiSGZGZEhkN1VUZVNkaktZY2hYaWdvcGYwSTJXMVRHeUh3?oc=5","date":"2025-08-27","type":"pipeline","source":"Stock Titan","summary":"CURX Stock Price, News & Analysis - Stock Titan","headline":"CURX Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-08-12","type":"pipeline","source":"simplywall.st","summary":"Analysts Expect Breakeven For Humacyte, Inc. (NASDAQ:HUMA) Before Long - simplywall.st","headline":"Analysts Expect Breakeven For Humacyte, Inc. (NASDAQ:HUMA) Before Long","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE9SY1V4OEdHSnNWM0JXSXUxemFia0xTSmlfeE5ZRTg0MXJsOFZsRUs3MkZTU29hWnNEWWg1RGlJdmFKcmNZQ282UDVsODNsR1FNNU5qaUpwUG9UTjR2ZVdiVm53Zl83NzYzVElN?oc=5","date":"2025-07-16","type":"pipeline","source":"MarketBeat","summary":"Jason Kolbert Analyst Performance at D. Boral Capital - MarketBeat","headline":"Jason Kolbert Analyst Performance at D. Boral Capital","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAJBVV95cUxNNVhTZU5mQUs2QjBza2ZDbWRYYUlBRVhvZS1aeThvaFlhNC1SMXZLSXl3VHU3UUlFTlV3UXJOMERzQTdUdll3ODZwMzlGRW1yWlJhQkZJb3phSWQyNlFNQ2tidmRMNXZySVNvaV9JMTZtamJJazMxekJOeFJOME5ISDZaTURlcG91WlNlbzA3MzdCSmxVdmppQ3ZsUlM4R1pNNVBmbzNWM0Y0YXBCWW1XbWF3eXo5MDVQQ2g1UEdWcWx6Tm1EaVVNVmd2c2wzbU1VMGllbUtsT19ueXNIMmV6VkFUNTE0UmNleXlmWTNYbmt5SXFJcFc0b0tHc2JlR1Z6UGZzUk1lSzdDdHhxRzFFNkRST09GTERQRXg5dDZOTmQ?oc=5","date":"2025-01-15","type":"pipeline","source":"businesswire.com","summary":"Deadline Soon: Humacyte, Inc. (HUMA) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit - businesswire.com","headline":"Deadline Soon: Humacyte, Inc. (HUMA) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Se","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNVDdzeE1NTzFhQjlFVVQ2cHFXUHVKMnZ4YWRJdEpCeTR0NTN1MEJmbHp4eFZMSVB2X210THRjRFBTWGt6T1BWSE9QbTN6ZjNXYjZjck9Dblc1YmNreTZoamh0X2s2bm9vdzNrTEdjWXR4SUJMVG90NkJiOHIwMHFLMEwyTDlNTElKc3U2RldPRy1IUVpWUUtoZ3NxLS1TNms?oc=5","date":"2024-12-20","type":"regulatory","source":"Pharmacy Times","summary":"FDA Approves Symvess for Treatment of Extremity Vascular Trauma - Pharmacy Times","headline":"FDA Approves Symvess for Treatment of Extremity Vascular Trauma","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQeHNwamVrLVZVRzE4bmp3d0NGbE9JX0t4Tkp3OEd0cUhCcHlUczdCY0NBT0dWdmlwOGNKaGItN1pBclRMMnppYVJYMzkxSWZQV2lCTUVrM2pxaDFublhhSHh6MHdSMkFiZ1NzeGdLSWh2TUpDamRSZ25rcmhubEVMX0dvZHVzb0dBaU5XcmdTVDh6UmpkZWNHT2RBbnV6bUVBYnZ5TGMtcTctbWs2aElPRXpNd3U4dDVRdjIxN3hBU0xodw?oc=5","date":"2024-08-09","type":"regulatory","source":"Reuters","summary":"US FDA extends review of Humacyte's blood vessel implant - Reuters","headline":"US FDA extends review of Humacyte's blood vessel implant","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}